EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Superior vena cava syndrome: A real-world analysis of 91 cases

Aurora Gómez-Tórtola, Olaya Huergo-Fernández, Laura Plaza-Martínez, Lucía Ordieres-Ortega, Crhistian-Mario Oblitas, Francisco Galeano-Valle, Pablo Demelo-Rodríguez

Medicina Clínica · 2026-07 · 166 (7) · 107431

DOI: 10.1016/j.medcli.2026.107431 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Medicina Clínica, 2026-07. Verfasst von Aurora Gómez-Tórtola und 6 weiteren Autor:innen. Beteiligte Einrichtung: Venous Thromboembolism Unit, Internal Medicine Department, Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain. Hauptthemen laut MEDLINE: Superior Vena Cava Syndrome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND Superior vena cava (SVCS) is an uncommon but potentially life-threatening condition caused by partial or complete obstruction of venous return through the superior vena cava, most commonly due to malignancy or catheter-related thrombosis. While SVCS is clinically relevant, contemporary data describing its presentation, management, and outcomes remain limited. The primary objective of this study was to describe the clinical characteristics, treatments, and outcomes of this population, and the secondary objective was to identify factors associated with mortality. METHOD Retrospective, single-center observational study including patients over 18 years of age diagnosed with SVCS between 2012 and 2023. Data were collected from electronic medical records. SVCS was confirmed by imaging. Life-threatening presentations were defined by the presence of cerebral or laryngeal edema, hemodynamic instability, or ICU admission. RESULTS Ninety-one patients were included (mean age 59.5 years; 51.6% women). Most cases were malignancy-related (90.1%), primarily lung cancer (50.5%). At diagnosis, 26.4% had life-threatening symptoms and 19.8% had concurrent venous thromboembolism. Interventional treatment was required in 38.4%, with stenting being the most common procedure. During follow-up (median 124 days), 82.4% of patients died, mainly from cancer progression. Mortality was associated with older age, corticosteroid use, and malignancy. Thrombotic etiology and incidental diagnosis were linked to better outcomes. In multivariate analysis, lung cancer remained an independent predictor of mortality (OR 4.67; 95% CI: 1.05-23.4). CONCLUSION In this cohort, SVCS was predominantly associated with malignancy, mainly lung cancer, and carried a high mortality rate. Catheter-related and thrombotic SVCS showed more favorable outcomes, emphasizing the prognostic importance of the underlying etiology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Superior Vena Cava SyndromeHumansFemaleRetrospective StudiesMaleMiddle AgedAgedAdultStentsAged, 80 and over

Stichwörter der Autor:innen

CancerCatheter-associated thrombosisEndovascular stentingPrognosisPronósticoStent endovascularSuperior vena cava syndromeSíndrome de vena cava superiorTrombosis asociada a catéter

Autor:innen und Institutionen

  • Venous Thromboembolism Unit, Internal Medicine Department, Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain.
  • School of Medicine, Universidad Complutense de Madrid, 28040 Madrid, Spain.
  • Venous Thromboembolism Unit, Internal Medicine Department, Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain; School of Medicine, Universidad Complutense de Madrid, 28040 Madrid, Spain; Sanitary Resea…
  • Internal Medicine Department, Hospital Clínico de Santiago, Galicia, Spain; Instituto de Investigación Sanitaria de Santiago, Galicia, Spain.

Zitieren

APA

Gómez-Tórtola, A., Huergo-Fernández, O., Plaza-Martínez, L., Ordieres-Ortega, L., Oblitas, C. M., Galeano-Valle, F., & Demelo-Rodríguez, P. (2026). Superior vena cava syndrome: A real-world analysis of 91 cases. Medicina Clínica, 166(7), 107431. https://doi.org/10.1016/j.medcli.2026.107431

Vancouver

Gómez-Tórtola A, Huergo-Fernández O, Plaza-Martínez L, Ordieres-Ortega L, Oblitas CM, Galeano-Valle F, et al. Superior vena cava syndrome: A real-world analysis of 91 cases. Medicina Clínica. 2026;166(7):107431. doi:10.1016/j.medcli.2026.107431

BibTeX
@article{GmezTrtola2026,
  author = {Gómez-Tórtola, Aurora and Huergo-Fernández, Olaya and Plaza-Martínez, Laura and Ordieres-Ortega, Lucía and Oblitas, Crhistian-Mario and Galeano-Valle, Francisco and Demelo-Rodríguez, Pablo},
  title = {Superior vena cava syndrome: A real-world analysis of 91 cases},
  journal = {Medicina Clínica},
  year = {2026},
  volume = {166},
  number = {7},
  pages = {107431},
  doi = {10.1016/j.medcli.2026.107431}
}
Kostenlos starten →